ReviewEClinicalMedicine2026

Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trials.

Hsien-Chung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.